The DOI matches its Crossref record; 51 of the 51 references it cites were found in a registry or an index.
Endogenous Testosterone and Mortality Due to All Causes, Cardiovascular Disease, and Cancer in Men: European Prospective Investigation Into Cancer in Norfolk (EPIC-Norfolk) Prospective Population Study
Abstract
Background— The relation between endogenous testosterone concentrations and health in men is controversial. Methods and Results— We examined the prospective relationship between endogenous testosterone concentrations and mortality due to all causes, cardiovascular disease, and cancer in a nested case-control study based on 11 606 men aged 40 to 79 years surveyed in 1993 to 1997 and followed up to 2003. Among those without prevalent cancer or cardiovascular disease, 825 men who subsequently died were compared with a control group of 1489 men still alive, matched for age and date of baseline visit. Endogenous testosterone concentrations at baseline were inversely related to mortality due to all causes (825 deaths), cardiovascular disease (369 deaths), and cancer (304 deaths). Odds ratios (95% confidence intervals) for mortality for increasing quartiles of endogenous testosterone compared with the lowest quartile were 0.75 (0.55 to 1.00), 0.62 (0.45 to 0.84), and 0.59 (0.42 to 0.85), respectively ( P <0.001 for trend after adjustment for age, date of visit, body mass index, systolic blood pressure, blood cholesterol, cigarette smoking, diabetes mellitus, alcohol intake, physical activity, social class, education, dehydroepiandrosterone sulfate, androstanediol glucuronide, and sex hormone binding globulin). An increase of 6 nmol/L serum testosterone (≈1 SD) was associated with a 0.81 (95% confidence interval 0.71 to 0.92, P <0.01) multivariable-adjusted odds ratio for mortality. Inverse relationships were also observed for deaths due to cardiovascular causes and cancer and after the exclusion of deaths that occurred in the first 2 years. Conclusions— In men, endogenous testosterone concentrations are inversely related to mortality due to cardiovascular disease and all causes. Low testosterone may be a predictive marker for those at high risk of cardiovascular disease.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Likewise, low testosterone levels in men are related to adverse events including increased cardiovascular and all-cause mortality [6–9].”
From Effects of vitamin D supplementation on androgens in men with low testosterone levels: a randomized controlled trial (2019) · cites this paper as [6]
In the citing paper
“With advancing age, testosterone levels drop, and testosterone deficiency is associated with early death, primarily from cardiovascular disease, a decrease in muscle mass and/or strength, and sexual dysfunction (46).”
From Sex-Based Differences in Skeletal Muscle Kinetics and Fiber-Type Composition (2015) · cites this paper as [46]
Citations
Cites
Writing Group for the Women's Health Initiative Investigators (2002) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.288.3.321 · Cited by 15,889
Hulley, S. (1998) · JAMA · doi:10.1001/jama.280.7.605 · Cited by 6,216
Huggins, C., & Hodges, C. V. (2002) · The Journal of Urology · doi:10.1016/s0022-5347(05)64820-3 · Cited by 3,856
Ding, E. L., Song, Y., Malik, V. S., & Liu, S. (2006) · JAMA · doi:10.1001/jama.295.11.1288 · Cited by 1,354
Advances in Male Contraception
Page, S. T., Amory, J. K., & Bremner, W. J. (2008) · Endocrine Reviews · doi:10.1210/er.2007-0041 · Cited by 1,138
The Decline of Androgen Levels in Elderly Men and Its Clinical and Therapeutic Implications
Kaufman, J. M., & Vermeulen, A. (2005) · Endocrine Reviews · doi:10.1210/er.2004-0013 · Cited by 1,079
Wareham, N. J., Jakes, R. W., Rennie, K. L., Schuit, A. J., Mitchell, J., Hennings, S., & Day, N. (2003) · Public Health Nutrition · doi:10.1079/phn2002439 · Cited by 852
Self-citationDay, N., Oakes, S., Luben, R., Khaw, K., Bingham, S., Welch, A., & Wareham, N. (1999) · Nature · doi:10.17863/cam.89388 · Cited by 780
Self-citationRisks of testosterone-replacement therapy and recommendations for monitoring.
Rhoden, E. L., & Morgentaler, A. (2004) · New England Journal of Medicine · doi:10.1056/nejmra022251 · Cited by 705
Androgens and Cardiovascular Disease
Liu, P. Y., Death, A. K., & Handelsman, D. J. (2003) · Endocrine Reviews · doi:10.1210/er.2003-0005 · Cited by 695
Flagged first, then by citations
Cited by
Sorted by citations
Items 401–500 of 742
Endogenous testosterone and mortality risk
Meyer, E. J., & Wittert, G. (2018) · Asian Journal of Andrology · doi:10.4103/aja.aja_70_17 · Cited by 17
Wang, A., Arver, S., Boman, K., Gerstein, H. C., Lee, S. F., Hess, S., Rydén, L., & Mellbin, L. (2018) · European Journal of Preventive Cardiology · doi:10.1177/2047487318819142 · Cited by 17
Young, A. P., Zhu, J., Bagher, A. M., Denovan‐Wright, E. M., Howlett, S. E., & Kelly, M. E. M. (2021) · GeroScience · doi:10.1007/s11357-020-00309-7 · Cited by 17
Alqahtani, S. A., & Alhawiti, N. M. (2018) · Platelets · doi:10.1080/09537104.2018.1499886 · Cited by 16
Testicular Dysfunction in Systemic Diseases
Sartorius, G. A., & Handelsman, D. J. (2010) · Springer eBooks · doi:10.1007/978-3-540-78355-8_18 · Cited by 16
Khera, M., Miner, M. M., Jaffe, J. S., & Pastuszak, A. W. (2020) · The Journal of Sexual Medicine · doi:10.1016/j.jsxm.2020.10.019 · Cited by 16
Liao, H., Chen, G., Wu, M., Liao, W., Tsai, I., & Kuo, C. (2014) · Journal of Chromatography A · doi:10.1016/j.chroma.2014.11.073 · Cited by 16
Samaras, N., Samaras, D., Lang, P. O., Forster, A., Pichard, C., Frangos, E., & Meyer, P. (2012) · Maturitas · doi:10.1016/j.maturitas.2012.11.009 · Cited by 16
The Significance of Low Testosterone Levels in Obese Men
Pelusi, C., & Pasquali, R. (2012) · Current Obesity Reports · doi:10.1007/s13679-012-0029-4 · Cited by 16
Aging US males with multiple sources of emotional social support have low testosterone
Gettler, L. T., & Oka, R. (2015) · Hormones and Behavior · doi:10.1016/j.yhbeh.2015.10.003 · Cited by 16
Park, J., Flores, A. J., Aschbacher, K., & Mendes, W. B. (2018) · Cultural Diversity & Ethnic Minority Psychology · doi:10.1037/cdp0000185 · Cited by 17
Taira, A. V., Merrick, G. S., Galbreath, R. W., Butler, W. M., Wallner, K. E., Allen, Z. A., Lief, J. H., & Adamovich, E. (2008) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2008.09.046 · Cited by 16
Frías-Toral, E., Chapela, S. P., Carignano, M. D. L. A., Moretti, D., Martinuzzi, A. L. N., Veintimilla, D. R., Guerrero, M., Pugliese, G., Muscogiuri, G., & Barrea, L. (2021) · Endocrines · doi:10.3390/endocrines2040034 · Cited by 16
Safety of testosterone therapy in men with prostate cancer
Morgentaler, A., & Caliber, M. (2019) · Expert Opinion on Drug Safety · doi:10.1080/14740338.2019.1666103 · Cited by 15
Experimentally elevated testosterone shortens telomeres across years in a free‐living songbird
Heidinger, B. J., Slowinski, S. P., Sirman, A. E., Kittilson, J. D., Gerlach, N. M., & Ketterson, E. D. (2021) · Molecular Ecology · doi:10.1111/mec.15819 · Cited by 15
Role of circulating molecules in age-related cardiovascular and metabolic disorders
Hsiao, Y., Shimizu, I., Yoshida, Y., & Minamino, T. (2022) · Inflammation and Regeneration · doi:10.1186/s41232-021-00187-2 · Cited by 16
Testosterone Replacement Therapy Improves QTaVI in Hypogonadal Men with Spinal Cord Injury
Fountaine, M. F. L., Wecht, J. M., Cirnigliaro, C. M., Kirshblum, S., Spungen, A. M., & Bauman, W. A. (2013) · Neuroendocrinology · doi:10.1159/000347070 · Cited by 15
Ramachandran, S., Strange, R. C., Fryer, A. A., Saad, F., & Hackett, G. I. (2018) · Andrology · doi:10.1111/andr.12520 · Cited by 15
Hosseini‐Marnani, E., Mollahosseini, M., Gheflati, A., Ghadiri‐Anari, A., & Nadjarzadeh, A. (2019) · Andrologia · doi:10.1111/and.13343 · Cited by 15
Wu, T., Gao, Y., Zheng, Y., Ma, Y., & Xie, X. (2019) · Clinical and Experimental Pharmacology and Physiology · doi:10.1111/1440-1681.13146 · Cited by 15
Effect of Androgen Deprivation Therapy on Metabolic Complications and Cardiovascular Risk
Melloni, C., & Nelson, A. J. (2019) · Journal of Cardiovascular Translational Research · doi:10.1007/s12265-019-09942-w · Cited by 15
Gautam, P., Cherbuin, N., Sachdev, P. S., Wen, W. X., & Anstey, K. J. (2013) · Neuroradiology · doi:10.1007/s00234-013-1144-y · Cited by 15
Testosterone levels and cardiovascular disease: Figure 1
Ronald, C. W., & Tong, P. C. Y. (2010) · Heart · doi:10.1136/hrt.2010.207068 · Cited by 15
Hormonal Signaling Actions on Kv7.1 (KCNQ1) Channels
Thompson, E., Eldstrom, J., & Fedida, D. (2020) · The Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev-pharmtox-010919-023645 · Cited by 14
Chen, Z., Qureshi, A. R., Brismar, T. B., Ripsweden, J., Haarhaus, M. L., Barany, P. F., Heimbürger, O., Lindholm, B., & Stenvinkel, P. (2019) · BMC Nephrology · doi:10.1186/s12882-019-1235-z · Cited by 14
Converse, A., & Thomas, P. (2021) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2021.111461 · Cited by 14
Anti-aging medicine: pitfalls and hopes
Dominguez, L. J., Barbagallo, M., & Morley, J. E. (2009) · The Aging Male · doi:10.1080/13685530902814434 · Cited by 14
Testosterone treatment and cardiovascular events in prescription database studies
Shores, M. M. (2017) · Asian Journal of Andrology · doi:10.4103/aja.aja_25_17 · Cited by 15
Gleicher, S., Daugherty, M., Ferry, E., & Byler, T. (2020) · International Urology and Nephrology · doi:10.1007/s11255-020-02557-0 · Cited by 14
Yamaguchi, K., Ishikawa, T., Chiba, K., & Fujisawa, M. (2010) · Andrologia · doi:10.1111/j.1439-0272.2009.01015.x · Cited by 14
Associations of endogenous testosterone and lipid profiles in middle-aged to older Taiwanese men
Jiann, B.-P., Hsieh, J.-T., Liu, S.-P., Hsu, S. H.-J., & Wu, H.-C. (2011) · International Journal of Impotence Research · doi:10.1038/ijir.2011.5 · Cited by 14
Hormones and Cardiovascular Disease in Older Men
Yeap, B. B., & Flicker, L. A. (2014) · Journal of the American Medical Directors Association · doi:10.1016/j.jamda.2013.12.004 · Cited by 15
Hypotestosteronaemia in the aging male: should we treat it?
Christe, N., & Meier, C. (2015) · Swiss Medical Weekly · doi:10.4414/smw.2015.14216 · Cited by 14
Liao, P.-W., Wu, C., Chen, K., Jaw, F.-S., Yu, H., Liu, S., & Ho, C. (2016) · The Journal of Sexual Medicine · doi:10.1016/j.jsxm.2016.10.002 · Cited by 14
Hackett, G. I. (2017) · Sexual Medicine Reviews · doi:10.1016/j.sxmr.2017.02.002 · Cited by 13
Hackett, G. I. (2012) · International Journal of Clinical Practice · doi:10.1111/j.1742-1241.2012.02922.x · Cited by 13
Testosterone is not associated with mortality in older African-American males
Cummings‐Vaughn, L. A., Malmstrom, T. K., Morley, J. E., & Miller, D. K. (2010) · The Aging Male · doi:10.3109/13685538.2010.502269 · Cited by 13
Jankowska, E. A., Tkaczyszyn, M., Kalicińska, E., Banasiak, W., & Ponikowski, P. P. (2014) · Kardiologia Polska · doi:10.5603/kp.a2014.0025 · Cited by 13
In Search for a Common Pathway for Health Issues in Men - the Sign of a Holmesian Deduction
Aoun, F. Y., Chemaly, A. K., Albisinni, S., Zanaty, M., & Roumeguère, T. (2016) · Asian Pacific Journal of Cancer Prevention · doi:10.7314/apjcp.2016.17.1.1 · Cited by 13
Liu, P., Li, X., Song, F., Li, P., Wei, J., Yan, Q., Xu, X., Yang, J., Li, C., & Fu, X. (2017) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2017.02.005 · Cited by 13
Wong, P. W., Lee, H. M., Lau, E. S. H., Lim, C. K. P., Ronald, C. W., Kong, A. P. S., Chan, J. C. N., & Luk, A. O. Y. (2018) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.3081 · Cited by 13
Kim, M., Kyung, Y. S., & Ahn, T. Y. (2019) · The World Journal of Men s Health · doi:10.5534/wjmh.190030 · Cited by 13
Billups, K. L., Miner, M. M., Wierzbicki, A. S., & Jackson, G. (2010) · International Journal of Clinical Practice · doi:10.1111/j.1742-1241.2010.02564.x · Cited by 13
The Female Stroke Survival Advantage: Relation to Age
Olsen, T. S., Dehlendorff, C., & Andersen, K. K. (2008) · Neuroepidemiology · doi:10.1159/000170906 · Cited by 13
Shafighi, M., Olariu, R., Brun, C., Fathi, A. R., Djafarzadeh, S., Jakob, S. M., Hunger, R. E., Banič, A., & Constantinescu, M. A. (2012) · Microsurgery · doi:10.1002/micr.21996 · Cited by 13
Testosterone deficiency syndrome (TDS) and the heart
Jackson, G. (2010) · European Heart Journal · doi:10.1093/eurheartj/ehq096 · Cited by 13
Wang, Z., Zhang, G. H., Hu, S., Fu, M., Zhang, P., Zhang, K., Hao, L., & Chen, S. (2024) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2024.116764 · Cited by 13
Plasma sex hormone levels and mortality in disabled older men and women
Fukai, S., Akishita, M., Yamada, S., Ogawa, S., Yamaguchi, K., Kozaki, K., Toba, K., & Ouchi, Y. (2010) · Geriatrics and gerontology international/Geriatrics & gerontology international · doi:10.1111/j.1447-0594.2010.00670.x · Cited by 12
Men's Sexual Health and the Metabolic Syndrome
MEULEMAN, E. J. H. (2011) · The Journal of Sex Research · doi:10.1080/00224499.2011.558646 · Cited by 12
SHBG and endothelial function in older subjects
Maggio, M. G., Cattabiani, C., Lauretani, F., Mantovani, M., Buttò, V., Vita, F. D., Volpi, R., Artoni, A., Giallauria, F., Zuliani, G., et al. (2013) · International Journal of Cardiology · doi:10.1016/j.ijcard.2013.03.083 · Cited by 12
Role of Sex in Atherosclerosis: Does Sex Matter?
Trivedi, B. S., Desai, R., Mishra, K., Hechanova, L. A., & Abolbashari, M. (2022) · Current Cardiology Reports · doi:10.1007/s11886-022-01800-7 · Cited by 12
Sert, İ., Kurtulmuş, Y., Karaca, C., Töz, H., Kürşat, S., & Çolak, H. (2014) · Saudi Journal of Kidney Diseases and Transplantation · doi:10.4103/1319-2442.139862 · Cited by 12
Vlachopoulos, C. V., Pietri, P., Ioakeimidis, N., Aggelis, A., Terentes-Printzios, D. G., Abdelrasoul, M., Gourgouli, I., Stefanadis, C., & Tousoulis, D. (2016) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2016.04.018 · Cited by 12
Testosterone replacement therapy and the heart: friend, foe or bystander?
López, D. S., Canfield, S. E., & Wang, R. (2016) · Translational Andrology and Urology · doi:10.21037/tau.2016.10.02 · Cited by 12
Gaba, A., Mairhofer, M., Zhegu, Z., Leditznig, N., Szabo, L., Tschugguel, W., Schneeberger, C., & Yotova, I. (2018) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2018.05.007 · Cited by 13
Sun, K., Wang, C., Lao, G., Lin, D., Huang, C., Li, N., Li, L., Li, F., Xiao, H., & Yan, L. (2020) · BMJ Open · doi:10.1136/bmjopen-2019-033991 · Cited by 12
Low free testosterone in HIV ‐infected men is not associated with subclinical cardiovascular disease
Monroe, A. K., Dobs, A. S., Xu, X., Palella, F., Kingsley, L., Post, W. S., Witt, M., & Brown, T. T. (2012) · HIV Medicine · doi:10.1111/j.1468-1293.2011.00988.x · Cited by 12
Endocrine Aspects of Chronic Kidney Disease
Carrero, J. J., Stenvinkel, P., & Lindholm, B. (2011) · Elsevier eBooks · doi:10.1016/b978-1-4160-6193-9.10057-0 · Cited by 12
Testosterone and aging male, a perspective from a developing country
Hoai, B. N., Long, H., Thắng, N. C., Pham, Q. M., & Jannini, E. A. (2023) · The Aging Male · doi:10.1080/13685538.2023.2223712 · Cited by 11
Cardio-oncology in advanced prostate cancer
Chen, K., Wong, T. H., Tan, Y. G., Tay, K. J., Tan, W. C., Chan, J., Ho, H. S. S., Cheng, C. W. S., Teoh, J. Y., Chiu, P. K., et al. (2024) · Frontiers in Oncology · doi:10.3389/fonc.2024.1386597 · Cited by 11
Testosterone replacement therapy for late-onset hypogonadism: current trends in Korea
Ko, Y. H., & Kim, J. J. (2011) · Asian Journal of Andrology · doi:10.1038/aja.2010.124 · Cited by 11
Allan, C. A., Peverill, R. E., Strauss, B. J., Forbes, E. A., & McLachlan, R. I. (2011) · Asian Journal of Andrology · doi:10.1038/aja.2011.13 · Cited by 11
Low Serum Testosterone as a New Risk Factor for Chronic Rejection in Heart Transplanted Men
Caretta, N., Feltrin, G., Tarantini, G., d’Agostino, C., Tona, F., Selice, R., Krajcar, T., Minicuci, N., Gerosa, G., & Foresta, C. (2013) · Transplantation · doi:10.1097/tp.0b013e31829b0893 · Cited by 11
Bušić, Ž., & Čulić, V. (2015) · World Journal of Cardiology · doi:10.4330/wjc.v7.i9.504 · Cited by 11
Kalicińska, E., Wojtas, K., Majda, J., Zacharski, M., Skiba, J., Śliwowski, J., Banasiak, W., Ponikowski, P. P., & Jankowska, E. A. (2018) · The Aging Male · doi:10.1080/13685538.2018.1494144 · Cited by 11
Hypogonadism and cancer survivorship
Faw, C. A., & Brannigan, R. E. (2020) · Current Opinion in Endocrinology Diabetes and Obesity · doi:10.1097/med.0000000000000583 · Cited by 11
Jabaloyas, J. M. M., Zaragoza, A., Cortés, C., Zaragozá, J. A. Q., Salom, M. G., & Nuez, P. C. (2008) · Actas Urológicas Españolas · doi:10.1016/s0210-4806(08)73895-6 · Cited by 11
Rojas, M. M., Villalpando, D. M., Ferrer, M., Alexander-Aguilera, A., & Garcia, H. S. (2019) · European Journal of Lipid Science and Technology · doi:10.1002/ejlt.201900098 · Cited by 11
Bordallo, J., Secades, L., Bordallo, C., Cantabrana, B., & Sánchez, M. (2008) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2008.12.019 · Cited by 11
Moreno, Ó., Pico, A. M., & Portilla, J. (2009) · Medicina Clínica · doi:10.1016/j.medcli.2008.07.018 · Cited by 11
Kava, B. (2014) · Current Urology Reports · doi:10.1007/s11934-014-0422-5 · Cited by 10
Prevalence of co-morbidities in patients with erectile dysfunction
Martínez-Jabaloyas, J. M. (2013) · Actas Urológicas Españolas (English Edition) · doi:10.1016/j.acuroe.2012.04.015 · Cited by 10
Sex hormones and cause-specific mortality in the male veterans: the Vietnam Experience Study
Phillips, A. C., Galé, C. R., & Batty, G. D. (2011) · QJM · doi:10.1093/qjmed/hcr204 · Cited by 10
Ho, C., Wu, C., Lee, M., Huang, P.-H., Chen, J.-T., Liu, S., & Liao, P.-W. (2019) · American Journal of Men s Health · doi:10.1177/1557988319847097 · Cited by 10
Testosterone therapy in hypogonadal patients and the associated risks of cardiovascular events
Kharaba, Z. J., Buabeid, M. A., Ibrahim, N. A., Jirjees, F., Al-Obaidi, H. J., Kaddaha, A., Khajehkarimoddini, L., & Alfoteih, Y. (2020) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2020.110423 · Cited by 10
Goncharov, N., Katsya, G. V., Gaivoronskaya, L. M., Zoloedov, V. I., Uskov, V. L., & Gooren, L. J. (2012) · Hormone Molecular Biology and Clinical Investigation · doi:10.1515/hmbci-2012-0023 · Cited by 10
Clinical implication of endothelial progenitor cells
Foresta, C., Toni, L. D., Ferlin, A., & Mambro, A. D. (2009) · Expert Review of Molecular Diagnostics · doi:10.1586/erm.09.80 · Cited by 10
Koch, B., Gläser, S., Schäper, C., Krebs, A., Nauck, M. A., Dörr, M., Haring, R., Völzke, H., Felix, S. B., Ewert, R., et al. (2011) · Journal of Andrology · doi:10.2164/jandrol.110.010074 · Cited by 10
Androgen Deficiency in Heart Failure
Güder, G., Allolio, B., Angermann, C. E., & Störk, S. (2011) · Current Heart Failure Reports · doi:10.1007/s11897-011-0053-9 · Cited by 10
Androgen Receptor-Mediated Genomic Androgen Action Augments Ischemia-Induced Neovascularization
Lam, Y. T., Lecce, L., Tan, J. T. M., Bursill, C. A., Handelsman, D. J., & Ng, M. (2016) · Endocrinology · doi:10.1210/en.2016-1301 · Cited by 10
Sigalos, J. T., Pastuszak, A. W., & Khera, M. (2017) · Medical Clinics of North America · doi:10.1016/j.mcna.2017.10.011 · Cited by 10
Lam, Y. T., Hsu, C., Simpson, P. J. L., Dunn, L., Chow, R., Chan, K. H., Yong, A. S. C., Yu, Y. S., Sieveking, D. P., Lecce, L., et al. (2020) · Endocrinology · doi:10.1210/endocr/bqaa043 · Cited by 10
COMPLICATIONS OF ANDROGEN‐DEPRIVATION THERAPY IN PROSTATE CANCER: THE OTHER SIDE OF THE COIN
Hoffmann, P., & Schulman, C. (2008) · British Journal of Urology · doi:10.1111/j.1464-410x.2008.08293.x · Cited by 10
Prevention of coronary artery disease in men: Male hormone, female hormone, or both?
Yang, C., Wang, X., Geng, C., & Ding, H. (2010) · Medical Hypotheses · doi:10.1016/j.mehy.2010.07.053 · Cited by 9
Friedrich, N., Schneider, H. J., Haring, R., Nauck, M. A., Völzke, H., Kroemer, H. K., Dörr, M., Klotsche, J., Jung‐Sievers, C., Pittrow, D. B., et al. (2011) · Steroids · doi:10.1016/j.steroids.2011.10.005 · Cited by 9
Low Testosterone in Men with Cardiovascular Disease or Risk Factors: To Treat or Not To Treat?
Cassimatis, D. C., Crim, M. T., & WENGER, N. K. (2016) · Current Treatment Options in Cardiovascular Medicine · doi:10.1007/s11936-016-0496-0 · Cited by 9
Li, Y., Ren, Z., Gao, L., Ma, J., Gou, Y., Tan, W., & Liu, C. (2022) · Andrologia · doi:10.1111/and.14535 · Cited by 9
Hansen, L. S., Priskorn, L., Holmboe, S. A., Jensen, T. K., Hansen, A. H., Andersson, A., & Jørgensen, N. (2022) · Andrology · doi:10.1111/andr.13365 · Cited by 9
Transversal European survey on testosterone deficiency diagnosis
Behre, H. M., Christin‐Maître, S., Morales, A. M., & Tostain, J. (2012) · The Aging Male · doi:10.3109/13685538.2012.655704 · Cited by 9
Pagano, M. J., Fazio, A. D., Levy, A. C., RoyChoudhury, A., & Stahl, P. J. (2015) · Urology · doi:10.1016/j.urology.2015.12.030 · Cited by 9
Neuzillet, Y., Thuret, R., Kleinclauss, F., & Timsit, M. (2016) · The French Journal of Urology · doi:10.1016/j.purol.2016.08.013 · Cited by 9
A 3-year observation of testosterone deficiency in Chinese patients with chronic heart failure
Han, Y., Sun, W., Sun, G., Hou, X., Gong, Z., Xu, J., Bai, X., & Fu, L. (2017) · Oncotarget · doi:10.18632/oncotarget.19816 · Cited by 9
The patient's comorbidity burden correlates with the erectile dysfunction severity
García-Cruz, E., Carrión, A., Ajami, T., Álvarez, M. N., Correas, M. Á. S., García, B. A., García, J. V., González, C., Portillo, J. A., Romero-Otero, J., et al. (2017) · Actas Urológicas Españolas (English Edition) · doi:10.1016/j.acuroe.2017.03.012 · Cited by 9
Testosterona sérica e doença cardiovascular em homens
de Sá, E. Q. C., de Sá, F. C. F., Guedes, A. D., & Verreschi, I. T. N. (2009) · Arquivos Brasileiros de Endocrinologia & Metabologia · doi:10.1590/s0004-27302009000800004 · Cited by 9
Ukkola, O. H., Huttunen, T., Puurunen, V.-P., Piira, O.-P., Niva, J., Lepojärvi, S., Tulppo, M. P., & Huikuri, H. V. (2013) · Annals of Medicine · doi:10.3109/07853890.2012.711951 · Cited by 9
Jones, T. H. (2009) · BMJ · doi:10.1136/bmj.b352 · Cited by 9
Testosterone levels and heart failure in obese and non-obese men
Čulić, V., & Bušić, Ž. (2014) · International Journal of Cardiology · doi:10.1016/j.ijcard.2014.07.253 · Cited by 8
Update on the safety of testosterone therapy in cardiac disease
Aaronson, A. J., Morrissey, R. P., Nguyen, C. T., Willix, R., & Schwarz, E. R. (2011) · Expert Opinion on Drug Safety · doi:10.1517/14740338.2011.566213 · Cited by 8
Wang, A., Arver, S., Flanagan, J. N., Gyberg, V., Näsman, P., Ritsinger, V., & Mellbin, L. (2018) · Diabetes and Vascular Disease Research · doi:10.1177/1479164118802543 · Cited by 8
Androgenic steroids dysregulation and the risk of coronary artery disease
Joury, A., Alshehri, M. G., Li, L. Z., & Rezan, T. (2022) · Expert Review of Cardiovascular Therapy · doi:10.1080/14779072.2022.2077193 · Cited by 8
Metadata
- Authors
- Khaw, K.-T., Dowsett, M., Folkerd, E., Bingham, S., Wareham, N., Luben, R., Welch, A., & Day, N.
- Affiliations
- University of Cambridge (GB)
- Venue
- Circulation
- Published
- 2007-12-04
- Volume
- 116
- Issue
- 23
- Pages
- 2694-2701
- ISSN
- 0009-7322 (ISSN-L)
- 1524-4539
- OpenAlex
- W2136449685
- Cited by
- 743
- References
- 51
- Citations by year
- 2026: 8 · 2025: 17 · 2024: 16 · 2023: 26 · 2022: 28 · 2021: 29 · 2020: 32 · 2019: 26 · 2018: 41 · 2017: 39 · 2016: 39 · 2015: 51 · 2014: 51 · 2013: 56 · 2012: 56
- FWCI
- 40.92
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Circulation (publishedVersion)
- PubMed (publishedVersion)
- UEA Digital Repository (University of East Anglia) (submittedVersion)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Hormonal and reproductive studies
- Health Sciences › Medicine › Reproductive Medicine › Sperm and Testicular Function
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Prostate Cancer Treatment and Research
- Keywords
- endogenous testosterone, all-cause mortality, cardiovascular mortality, cancer mortality, men, androgen deficiency, sex hormones, cardiovascular risk prediction, sex hormone-binding globulin, dehydroepiandrosterone sulfate, androstanediol glucuronide
- MeSH terms
- Adult, Aged, Cardiovascular Diseases, Europe, Humans, Male, Middle Aged, Neoplasms, Predictive Value of Tests, Prospective Studies, Risk Factors, Testosterone
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review